Search
for
Sort by
Research 481–510 of 1000+
- Literature Review: Nutrafol<sup>®</sup> vs. Microinflammation
- 천연식물을 이용한 AT-Grow의 발모효과
- [Therapeutic effect of Impatiens balsamina, Lawsonia inermis L. and Henna on androgenetic alopecia in mice].
- Cosmeceuticals
- Unravelling the link between insulin resistance and androgen excess
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- What is the Rationale for Androgen Therapy for Women?
- Chapter 23. Therapeutic Control of Androgen Action
- Androgen replacement therapy in women
- Endocrinology of Hirsutism: From Androgens to Androgen Excess Disorders
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Effect of norplant on androgens and sexual function
- Androgens and ovarian function: translation from basic discovery research to clinical impact
- Treatment of Hirsutism With Spironolactone
- Androgens Protect against Apolipoprotein E4-Induced Cognitive Deficits
- Androgenic Effects on Ventricular Repolarization
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model
- Cardiometabolic profile of young women with hypoprolactinemia
- Polycystic ovary syndrome patients with high BMI tend to have functional disorders of androgen excess: a prospective study
- Simultaneous pharmacokinetic and pharmacodynamic analysis of 5α-reductase inhibitors and androgens by liquid chromatography tandem mass spectrometry
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Mitochondria Dysfunction and Inflammation in Traumatic Brain Injury: Androgens to the Battlefront
- The Role of 11-Oxygenated Androgens and Endocrine Disruptors in Androgen Excess Disorders in Women
- Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
- Alopecia and hirsutism*
- TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target
- Weekly treatment with SAMiRNA targeting the androgen receptor ameliorates androgenetic alopecia
- Steroid Hormones